Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panos Zanos

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
The Journal of Infectious Diseases|September 10, 2024
From Viral Infections to Alzheimer's Disease: Unveiling the Mechanistic Links Through Systems BioinformaticsAnna Onisiforou, Panos Zanos
Computational and Structural Biotechnology Journal|November 4, 2024
One path, two solutions: Network-based analysis identifies targetable pathways for the treatment of comorbid type II diabetes and neuropsychiatric disordersAnna Onisiforou, Panos Zanos
Biological Psychiatry|November 28, 2017
Intracellular Signaling Pathways Involved in (S)- and (R)-Ketamine Antidepressant ActionsPanos Zanos, Todd D Gould
Communications Medicine|February 27, 2026
Metformin provides superior neuroprotective potential compared to semaglutide in preventing diabetes-associated Alzheimer's disease via dual actionsAndrea Georgiou, Panos Zanos, Anna Onisiforou
Pharmacology, Biochemistry, and Behavior|February 25, 2023
Role of group II metabotropic glutamate receptors in ketamine's antidepressant actionsAnna Onisiforou, Polymnia Georgiou, Panos Zanos
Scientific Data|June 26, 2024
Molecular signatures of premature aging in Major Depression and Substance Use DisordersAnna Onisiforou, Panos Zanos, Polymnia Georgiou
Trends in Molecular Medicine|January 3, 2026
Major depressive disorder: susceptibility, underlying mechanisms, and emerging therapiesAnna Onisiforou, Morfeas Koumas, Panos Zanos
Microorganisms|January 25, 2025
Shattering the Amyloid Illusion: The Microbial Enigma of Alzheimer's Disease Pathogenesis-From Gut Microbiota and Viruses to Brain BiofilmsAnna Onisiforou, Eleftheria G Charalambous, Panos Zanos
Neuron|January 18, 2020
Antidepressant Effects and Mechanisms of Group II mGlu Receptor-Specific Negative Allosteric ModulatorsLiam E Potter, Panos Zanos, Todd D Gould
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 3, 2016
Ketamine Mechanism of Action: Separating the Wheat from the ChaffTodd D Gould, Panos Zanos, Carlos A Zarate
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
The Journal of Infectious Diseases|September 10, 2024
From Viral Infections to Alzheimer's Disease: Unveiling the Mechanistic Links Through Systems BioinformaticsAnna Onisiforou, Panos Zanos
Computational and Structural Biotechnology Journal|November 4, 2024
One path, two solutions: Network-based analysis identifies targetable pathways for the treatment of comorbid type II diabetes and neuropsychiatric disordersAnna Onisiforou, Panos Zanos
Biological Psychiatry|November 28, 2017
Intracellular Signaling Pathways Involved in (S)- and (R)-Ketamine Antidepressant ActionsPanos Zanos, Todd D Gould
Communications Medicine|February 27, 2026
Metformin provides superior neuroprotective potential compared to semaglutide in preventing diabetes-associated Alzheimer's disease via dual actionsAndrea Georgiou, Panos Zanos, Anna Onisiforou
Pharmacology, Biochemistry, and Behavior|February 25, 2023
Role of group II metabotropic glutamate receptors in ketamine's antidepressant actionsAnna Onisiforou, Polymnia Georgiou, Panos Zanos
Scientific Data|June 26, 2024
Molecular signatures of premature aging in Major Depression and Substance Use DisordersAnna Onisiforou, Panos Zanos, Polymnia Georgiou
Trends in Molecular Medicine|January 3, 2026
Major depressive disorder: susceptibility, underlying mechanisms, and emerging therapiesAnna Onisiforou, Morfeas Koumas, Panos Zanos
Microorganisms|January 25, 2025
Shattering the Amyloid Illusion: The Microbial Enigma of Alzheimer's Disease Pathogenesis-From Gut Microbiota and Viruses to Brain BiofilmsAnna Onisiforou, Eleftheria G Charalambous, Panos Zanos
Neuron|January 18, 2020
Antidepressant Effects and Mechanisms of Group II mGlu Receptor-Specific Negative Allosteric ModulatorsLiam E Potter, Panos Zanos, Todd D Gould
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 3, 2016
Ketamine Mechanism of Action: Separating the Wheat from the ChaffTodd D Gould, Panos Zanos, Carlos A Zarate
Pageof 8